Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. - Wikidata - awgldk - TriplyDB

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

http://www.wikidata.org/entity/Q42462932

about

Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?α-Synuclein induced toxicity in brain stem serotonin neurons mediated by an AAV vector driven by the tryptophan hydroxylase promoter.The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration.Hippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models.Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent Neurons.The relationships between mild cognitive impairment and phenotype in Parkinson's disease Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.Lewy body dementias.Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease.A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.Parkinson's disease dementia: a neural networks perspective.Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.Impaired Pain Processing Correlates with Cognitive Impairment in Parkinson's Disease.Cell Therapy in Parkinson's Disease: Host Brain Repair Machinery Gets a Boost From Stem Cell Grafts.Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline.Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology.1-Methyl-4-propan-2-ylbenzene from Thymus vulgaris Attenuates Cholinergic Dysfunction.A clinicopathological approach to the diagnosis of dementia.Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.Patterns of cortical thinning in nondemented Parkinson's disease patients.Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease.Extrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis.The BSSG rat model of Parkinson's disease: progressing towards a valid, predictive model of disease.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Parkinson's Disease Is Not Simply a Prion Disorder.Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease.Muscarinic receptor binding changes in postmortem Parkinson's disease.Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.Subtle alterations of excitatory transmission are linked to presynaptic changes in the hippocampus of PINK1-deficient mice.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis.Regional Overlap of Pathologies in Lewy Body Disorders.The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia.Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia.Genetic analysis of α-synuclein 3' untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies.Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.

P2860

Q27002626-633C9A06-3AED-4408-A158-404164AAECB1 Q27313863-335ACE44-ABB1-4E6F-AAF1-62B617CA6C20 Q27315090-53FD791A-F251-4CD4-A347-B4B5F418B543 Q28085513-D1FEB97B-6F77-4093-91AA-A75171325FD8 Q30244035-554C685C-DE0B-4DE1-88BE-C668A7C5E878 Q31060511-5CE8C775-E08B-496E-A4DD-28E20E56F63A Q33617563-99BCEEAF-DA6B-46BE-84BF-CAC019814F23 Q33917203-E24F45EC-2A1F-4F8E-860D-81E5E91E9FFC Q33917311-E651872D-D9A7-4A46-A7FA-B054F0CDBC7D Q34502646-6B28005C-6308-479F-B5AD-D184D5C82691 Q35649563-6CE724C3-E255-403B-9D78-2075ED0F96E8 Q36100354-F218457D-6574-45C8-A364-2C70664298BE Q36109452-C62A9110-039B-4819-8624-0F3B49F37B2D Q36186763-8EC3442B-4F34-4618-A9FE-E6C3BADD92D3 Q36372732-9610D5DF-A589-4EA3-AEAB-BC781FED782E Q37478879-FF020967-D902-4F44-9EDC-65F58AEED061 Q38686736-E6A657B1-F0E1-4193-B97C-B88921E2050A Q38961546-65488EA5-FCC8-4ACD-8696-850534BB0223 Q39048630-2230A373-F174-48BD-B95D-771CE81EDB26 Q39167697-9ECC3170-AADC-4C24-B05E-78AE98F1677C Q39434968-190EB2C9-0369-4601-BF49-5B023B6B2BF6 Q39464596-7A8D5ED9-3D41-4B9E-8556-3295D4397C4B Q39839169-CDF38B9E-DA12-41EF-9486-7CD23E791F66 Q40889520-D3F067A6-F44C-4739-BC8A-33E6C26D808D Q40936443-9DA9FA27-09CF-4306-B660-4A37B1EBA550 Q42364022-86ADBB77-804D-429D-8B11-EA3B01A3A884 Q46354756-C4A8203F-EB00-4434-84DE-DF91E319A190 Q47314960-A79CBA58-5377-4DBD-8855-7B0C4724946C Q47619917-2E828DC1-D9D2-4542-8F13-FD435D74817F Q47654564-53F1547C-2346-48CE-9281-D0A356A3561B Q47871275-9613664D-6A8E-4CB8-AE03-B62AA78C702B Q48201813-25AF2905-BEB4-4C64-AFCE-3C0F25827B0A Q48924933-F965C4CE-8D30-4352-AEEF-030DC5F8A6C1 Q49987358-860B0E90-B35C-4B7A-9E51-8554B5C27B6F Q50068611-238D502D-651F-4F40-8D32-1A990C3B7F31 Q50211142-94FFB277-7E74-477C-ABC1-ED1192ED6654 Q50420457-4F9E40F8-072D-4950-ACC9-056E6C991B73 Q50420909-7DBD8A10-EE9C-4E03-8866-645ABB61AD00 Q50710454-551F242E-30F7-4952-8AA5-70EBF2138C4B Q51744776-3B777579-F177-48E9-992C-487738E7E524

P2860

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.

http://www.wikidata.org/entity/Q42462932

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Hippocampal Lewy pathology and ...... mentia in Parkinson's disease.

@en

Hippocampal Lewy pathology and ...... mentia in Parkinson's disease.

@nl

type

label

Hippocampal Lewy pathology and ...... mentia in Parkinson's disease.

@en

Hippocampal Lewy pathology and ...... mentia in Parkinson's disease.

@nl

prefLabel

Hippocampal Lewy pathology and ...... mentia in Parkinson's disease.

@en

Hippocampal Lewy pathology and ...... mentia in Parkinson's disease.

@nl

P1433

Q42462932-04E5C2FA-9A56-4DBF-AE54-5E4CE4DA698A

P1476

Q42462932-7806F0D3-188E-4BEB-9A5E-32432244DBCD

P2093

Q42462932-09953E99-32A6-4F18-8939-79FA793F0A6C

Q42462932-27EB8947-199A-4354-ADCB-E86DAF792D90

Q42462932-B2FDC700-14F9-4ED5-9713-F380B0A46F44

Q42462932-BC2F8908-DB11-44DC-8113-C318CD2D2E38

P2860

Q42462932-015F062D-94A0-4485-93F6-4E9003102DB2

Q42462932-03C334D3-B020-4849-9CDB-CE2E07251DB0

Q42462932-104A3B28-A430-4CCB-A5B8-38B8ACECB7A0

Q42462932-12D0A808-FD6B-44CF-A591-38843E8F46CE

Q42462932-1825F2CE-0123-433E-9D6E-CC13E2309262

Q42462932-197A6CA4-9737-4BFC-8BF9-D5CDED17C206

Q42462932-1D51A133-F95C-4384-9C25-90C714026EE6

Q42462932-29D913B9-FA1A-4A28-9B5C-4A0EB496B1C4

Q42462932-2BE8E86E-13BA-4F20-993D-E96AEE1C3897

Q42462932-2DD8C240-9CFF-4B34-94C2-957E1B3BEEE4

P304

Q42462932-514ED011-804E-4216-8C7F-75F1D90C9765

P31

Q42462932-8BCE15A4-D92E-4786-BBE5-93CF35E39CAD

P356

Q42462932-DE66E8B9-D382-42CE-B9D5-CC2A54B8100C

P407

Q42462932-3E80E6E5-12D4-4D7C-9797-BA1B8D26732B

P433

Q42462932-FC5D3744-18B1-4F36-BD03-616F559E5FCA

P478

Q42462932-F940E2DA-C2C8-49FC-BCA8-738E5727BC8A

P50

Q42462932-80059E93-0B23-4E60-A62D-94357229694C

Q42462932-CFFA1FDE-61E2-457B-BD26-ACE7692A2184

Q42462932-E039042E-AC76-4682-86AB-522D0F54C3D1

Q42462932-E79CF276-3446-4A35-AC43-84104B6117AB

Q42462932-FC916464-D583-4BF2-B248-2CFC71E9A27A

P577

Q42462932-342D847E-7215-487E-85F7-E41771E67485

P698

Q42462932-8D2473D3-6871-4195-9817-18D8810DD584

P921

Q42462932-027689BF-6E7E-46D2-BB44-30763A38CD58

Q42462932-4d849e98-94f8-4127-a454-346b8f6eaf66

Q42462932-D7A18B91-71B3-44C6-913B-F7226F994730

P356

P1433

P1476

Hippocampal Lewy pathology and ...... ementia in Parkinson's disease

@en

P2093

Deniz Kirik

http://www.w3.org/2001/XMLSchema#string

Giampiero Leanza

http://www.w3.org/2001/XMLSchema#string

Hélène Hall

http://www.w3.org/2001/XMLSchema#string

Stefanie Reyes

http://www.w3.org/2001/XMLSchema#string

P2860

Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

Neuropathologic substrates of Parkinson disease dementia.

What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias.

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease

Rivastigmine for dementia associated with Parkinson's disease.

The cholinergic system in aging and neuronal degeneration.

P304

2493-2508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWU193

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 9

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

Glenda Halliday

Natalie Landeck

Lachlan H Thompson

P577

2014-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25062696

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease